Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 7/2003

01-07-2003 | Original Article

Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

Authors: Elif Hindié, Didier Mellière, Françoise Lange, Iyad Hallaj, Claire de Labriolle-Vaylet, Christian Jeanguillaume, Jacques Lange, Léon Perlemuter, Serge Askienazy

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2003

Login to get access

Abstract

Functioning pulmonary metastases are the most common distant lesions of differentiated thyroid cancer. About 50% of patients with such metastases die within 10 years. The impact of iodine-131 therapy is controversial. In this study we examined: (1) the early diagnostic value of post-surgery 131I ablation for lung invasion and (2) the survival of patients receiving periodic 131I therapy. Between January 1970 and December 1995 we provided initial treatment for 509 patients with thyroid cancer. Most of them (74%) underwent total thyroidectomy and 131I ablation. Functioning pulmonary metastases occurred in 20 patients. All these patients received periodic 131I therapy for as long as 131I uptake persisted. Additional therapy consisted of lung surgery in three patients and local treatment of bone lesions in four patients. Follow-up data were recorded up to December 2001. Functioning pulmonary metastases occurred late in one patient, and were visible on the post-surgery 131I therapy scan in the other 19 patients. At diagnosis of lung invasion, 11 patients had negative chest X-ray findings, and serum thyroglobulin levels were not suggestive of metastatic disease in 56% of these cases. One of the 11 patients with negative chest X-ray findings died with a neck recurrence, two have persistent pulmonary 131I uptake, and the other eight are in apparent remission after receiving an average cumulative 131I activity of 338 mCi (12.51 GBq). The nine patients with positive chest X-ray findings received an average of 939 mCi (34.74 GBq); two of them died, five are continuing to receive therapy and two are in apparent remission. Overall survival at 10 years is 84%. The average follow-up of the 17 survivors is 12.7 years. These results suggest that patients with functioning pulmonary metastases, even in advanced stages, may survive for many years on 131I therapy. Early diagnosis, during post-surgery 131I scanning, of radiologically inapparent metastases is associated with a better prognosis.
Literature
1.
go back to reference Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999; 84:4043–4049.PubMed Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999; 84:4043–4049.PubMed
2.
go back to reference Massin J-P, Savoie J-C, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma: study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53:982–992.PubMed Massin J-P, Savoie J-C, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma: study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53:982–992.PubMed
3.
go back to reference Samaan NA, Scultz P, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985; 60:376–380.PubMed Samaan NA, Scultz P, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985; 60:376–380.PubMed
4.
go back to reference Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli M, Busnardo B. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626–1631.PubMed Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli M, Busnardo B. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626–1631.PubMed
5.
go back to reference Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated throid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67:501–508. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated throid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67:501–508.
6.
go back to reference Hoie J, Stenwig AE, Kullman G, Lindegaard M. Distant metastases in papillary thyroid cancer: a review of 91 patients. Cancer 1988; 61:1–6.PubMed Hoie J, Stenwig AE, Kullman G, Lindegaard M. Distant metastases in papillary thyroid cancer: a review of 91 patients. Cancer 1988; 61:1–6.PubMed
7.
go back to reference Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated thyroid carcinoma of the thyroid. Am J Surg 1996; 172:692–694.CrossRefPubMed Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated thyroid carcinoma of the thyroid. Am J Surg 1996; 172:692–694.CrossRefPubMed
8.
go back to reference Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastses of adenocarcinoma of the thyroid. JAMA 1946; 132:838–847. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastses of adenocarcinoma of the thyroid. JAMA 1946; 132:838–847.
9.
go back to reference Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323–327.PubMed Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323–327.PubMed
10.
go back to reference Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994; 18:600–604.PubMed Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994; 18:600–604.PubMed
11.
go back to reference Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598–605.PubMed Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598–605.PubMed
12.
go back to reference Varma VM, Beierwaltes WH, Nofal MM, Nishiyama RH, Copp JE. Treatment of thyroid cancer: death rates after surgery and after surgery followed by sodium iodide I-131. JAMA 1970; 214:1437–1442.CrossRefPubMed Varma VM, Beierwaltes WH, Nofal MM, Nishiyama RH, Copp JE. Treatment of thyroid cancer: death rates after surgery and after surgery followed by sodium iodide I-131. JAMA 1970; 214:1437–1442.CrossRefPubMed
13.
go back to reference Samaan NA, Schultz P, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714–720. Samaan NA, Schultz P, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714–720.
14.
go back to reference Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418–428.PubMed Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418–428.PubMed
15.
go back to reference Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84:3877–3885PubMed Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84:3877–3885PubMed
16.
go back to reference Turner JE, Weier GJ Jr. Pulmonary metastases from thyroid carcinoma detectable only by 131-I scan. J Nucl Med 1972; 13:852.PubMed Turner JE, Weier GJ Jr. Pulmonary metastases from thyroid carcinoma detectable only by 131-I scan. J Nucl Med 1972; 13:852.PubMed
17.
go back to reference Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. Therapeutic controversy: the use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998; 83:4195–4203.PubMed Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. Therapeutic controversy: the use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998; 83:4195–4203.PubMed
18.
go back to reference Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995; 80:2041–2045.PubMed Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995; 80:2041–2045.PubMed
19.
go back to reference Mellière D, Berrahal D, Hindié E, Becquemin JP, Lange F. Differentiated thyroid carcinoma: long term results of a management protocol based on simple prognostic criteria. Presse Med 1997; 26:1276–1283.PubMed Mellière D, Berrahal D, Hindié E, Becquemin JP, Lange F. Differentiated thyroid carcinoma: long term results of a management protocol based on simple prognostic criteria. Presse Med 1997; 26:1276–1283.PubMed
20.
go back to reference Marcocci C, Pacini F, Elisi R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989; 106:960–966.PubMed Marcocci C, Pacini F, Elisi R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989; 106:960–966.PubMed
21.
go back to reference Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001; 86:1568–1573.PubMed Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001; 86:1568–1573.PubMed
22.
go back to reference Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790–1794.PubMed Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790–1794.PubMed
23.
go back to reference Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39:1542–1546. Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39:1542–1546.
24.
go back to reference Vassilopoulou-Sellin R, Libshitz HI, Haynie TP. Papillary thyroid cancer with pulmonary metastases beginning in childhood. Clinical course over three decades. Med Pediatr Oncol 1995; 24:119–122.PubMed Vassilopoulou-Sellin R, Libshitz HI, Haynie TP. Papillary thyroid cancer with pulmonary metastases beginning in childhood. Clinical course over three decades. Med Pediatr Oncol 1995; 24:119–122.PubMed
25.
go back to reference Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998; 39:1531–1536.PubMed Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998; 39:1531–1536.PubMed
26.
go back to reference Shen DNH, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease. Thyroid 2001; 11:415–425.PubMed Shen DNH, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease. Thyroid 2001; 11:415–425.PubMed
27.
go back to reference Hindié E, Leenhardt L, Vitaux F, et al. Non-medical exposure to radioiodines and thyroid cancer. Eur J Nucl Med Mol Imaging 2002; 29 Suppl 2:S497–S512. Hindié E, Leenhardt L, Vitaux F, et al. Non-medical exposure to radioiodines and thyroid cancer. Eur J Nucl Med Mol Imaging 2002; 29 Suppl 2:S497–S512.
28.
go back to reference Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45–51.PubMed Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45–51.PubMed
29.
go back to reference Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995; 36:21–27.PubMed Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995; 36:21–27.PubMed
30.
go back to reference DeVathaire F, Schlumberger M, Delisle MJ, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 1997; 75:734–739.PubMed DeVathaire F, Schlumberger M, Delisle MJ, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 1997; 75:734–739.PubMed
31.
go back to reference Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA. Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 1998; 8:215–221.PubMed Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA. Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 1998; 8:215–221.PubMed
32.
go back to reference Helal BO, Merlet P, Toubert ME, et al. Clinical impact of18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy. J Nucl Med 2001; 42:1464–1469.PubMed Helal BO, Merlet P, Toubert ME, et al. Clinical impact of18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy. J Nucl Med 2001; 42:1464–1469.PubMed
33.
go back to reference Petrich T, Borner AR, Otto D, Hofmann M, Knapp WH. Influence of rhTSH on18F-fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002; 29:641–647.CrossRefPubMed Petrich T, Borner AR, Otto D, Hofmann M, Knapp WH. Influence of rhTSH on18F-fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002; 29:641–647.CrossRefPubMed
34.
go back to reference Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379:458–460.PubMed Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379:458–460.PubMed
35.
go back to reference Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002; 29:775–782.CrossRefPubMed Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002; 29:775–782.CrossRefPubMed
Metadata
Title
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
Authors
Elif Hindié
Didier Mellière
Françoise Lange
Iyad Hallaj
Claire de Labriolle-Vaylet
Christian Jeanguillaume
Jacques Lange
Léon Perlemuter
Serge Askienazy
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2003
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1174-5

Other articles of this Issue 7/2003

European Journal of Nuclear Medicine and Molecular Imaging 7/2003 Go to the issue

News & Views

July 2003